v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in Capital
Accumulated Earnings (Deficit)
Accumulated Other Comprehensive Loss
Beginning balances (in shares) at Dec. 31, 2024   295,757,002      
Beginning balances at Dec. 31, 2024 $ 1,056,084 $ 777,171 $ 166,361 $ 116,930 $ (4,378)
Number of Shares          
Shares issued and restricted stock units ("RSUs") vested under stock option plan (in shares)   2,598,750      
Shares issued and restricted stock units (“RSUs”) vested under stock option plan 151 $ 12,897 (12,746)    
Stock-based compensation 14,988   14,988    
Foreign currency translation adjustment (2,620)       (2,620)
Net loss (45,621)     (45,621)  
Ending balances (in shares) at Mar. 31, 2025   298,355,752      
Ending balances at Mar. 31, 2025 1,022,982 $ 790,068 168,603 71,309 (6,998)
Beginning balances (in shares) at Dec. 31, 2025   300,600,710      
Beginning balances at Dec. 31, 2025 966,904 $ 802,341 198,279 (29,482) (4,234)
Number of Shares          
Shares issued and restricted stock units ("RSUs") vested under stock option plan (in shares)   3,344,871      
Shares issued and restricted stock units (“RSUs”) vested under stock option plan 516 $ 14,192 (13,676)    
Stock-based compensation 12,013   12,013    
Foreign currency translation adjustment 1,815       1,815
Net loss (43,165)     (43,165)  
Ending balances (in shares) at Mar. 31, 2026   303,945,581      
Ending balances at Mar. 31, 2026 $ 938,083 $ 816,533 $ 196,616 $ (72,647) $ (2,419)